Encanto - The Power of cartilage.

22/12/2025

As we approach the festive season, we wish you joyful holidays filled with peace, warmth, and well-deserved moments of rest. :D
Looking ahead to the New Year, we are entering an important phase of our project and look forward to continuing strong collaborations, driving key innovations, and working together to achieve the ENCANTO goals!

18/11/2025

🔹 ENCANTO 4th General Assembly – Würzburg, Germany 🇩🇪

Last week, the ENCANTO consortium gathered for the 4th General Assembly, hosted by our partners at the University Hospital of Würzburg.

🔬 We are happy to report that patient recruitment has started in several clinical centers across Europe. After many months of preparation, regulatory work, and site setup, the clinical phase of the project is now officially underway.

💡 With 22 partners from 10 countries, ENCANTO continues to push forward in developing an innovative treatment for patellofemoral osteoarthritis using nasal cartilage (N-TEC technology).

Thanks to all our partners for the inspiring discussions, updates, and great collaboration!

Encanto - The Power of Cartilage

18/09/2025

ENCANTO has reached a major milestone: with full approval now secured across all countries, the first patients have already been recruited at USB and OSS. The journey moves forward with the very first treatment scheduled for 23 September 2025 — a pivotal step in bringing innovation to patients across Europe.

16/09/2025

ENCANTO has reached a major milestone: with full approval now secured across all countries, the first patients have already been recruited at University Hospital Basel and Orthopaedic Hospital Speising in Vienna!

The journey moves forward with the very first treatment scheduled for 23 September 2025 — a pivotal step in bringing innovation to patients across Europe.

25/08/2025

Orthopaedic Hospital Speising in Vienna, serving as Austria’s exclusive trial site, has started patient recruitment for the ENCANTO clinical study.
Curious to learn more in Austrian German language about how nasal cells could pave the way for cartilage regeneration and improved mobility? Check out the latest details from Krone and OTS, and explore how ENCANTO is reshaping the future of knee therapy.

https://www.ots.at/presseaussendung/OTS_20250807_OTS0022/innovative-arthrose-behandlung-nasenzellen-fuers-knie

https://www.krone.at/3855273

Im Rahmen einer EU-weiten Studie namens ENCANTO wird eine innovative Methode erprobt, bei der Zellen aus der Nase zur Behandlung von Kniearthrosen verwendet werden.

09/08/2025

14/07/2025

We’re live! The ENCANTO Project has officially launched its LinkedIn channel — your new hub for updates on our groundbreaking N‑TEC therapy for regenerating knee cartilage using the body’s own nasal cells.
Follow us here to stay informed on clinical milestones, collaborative breakthroughs, and the people behind this Horizon Europe–funded innovation in osteoarthritis treatment.
👉 https://lnkd.in/dmx3cmvf
hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

Encanto - The Power of Cartilage | 34 followers on LinkedIn. Innovative treatment that repairs damaged cartilage under the kneecap using a special cell therapy. | Encanto (ENgineered CArtilage from Nose for the Treatment of Osteoarthritis) is the latest innovative regenerative treatment that helps r...

04/07/2025

We’re excited to announce the launch of the official ENCANTO Project page!

Follow us to learn how we’re using the body’s own nasal cartilage cells to regenerate knee joints and transform osteoarthritis treatment. Stay up to date with news from our clinical trial, behind-the-scenes moments, and stories from the amazing teams across Europe making it happen.

👍 Like and follow us at facebook.com/encanto.health

Innovative treatment that repairs damaged cartilage under the kneecap using a special cell therapy.